Master switch discovery could provide road map for treatment of arthritis and other inflammatory diseases

January 23, 2013, University of British Columbia

(Medical Xpress)—Scientists trying to create drugs to treat chronic inflammation in diseases like arthritis now have a new culprit known MMP2. New University of British Columbia research shows that this enzyme works as a master switch to activate inflammatory diseases.

The research, published recently in Science Signaling, examined the role a group of enzymes known as MMP proteases play in inflammation. Arthritis is caused by excessive inflammation in an overactive immune system trying to repair damaged tissues. In patients with arthritis, the immune system mistakenly attacks healthy tissues, most commonly the joints. This attack leads to inflammation, pain and joint damage.

Chris Overall, a professor in the Faculty of Dentistry and Canada Research Chair in Metalloproteinase & Systems Biology, and his team found that the protease MMP2 can remove a block allowing inflammation to become activated. This pathway is often overactive in patients with arthritis and other .

"Imagine a cart parked on a hill with a rock behind its wheel to prevent it from rolling down the hill," said Overall. "We found that MMP2 can remove that rock, causing the immune response to activate."

According to Overall, who regularly employs arthritis as a disease model in his research, this is the first study to explain this pathway system.

"We were amazed by these results. This shows us a new way to design drugs to treat many chronic inflammatory diseases like arthritis and even periodontal disease," said Overall.

Findings also provide the basis for a new diagnosis screen such as a blood test to detect the disease before the severe damage to joints occurs.

Arthritis: Impact and treatment

  • First of its kind: Overall's study of MMP2 role in skin inflammation is the first and only of its kind. The approach is now being used around the world and can be applied to study the components in many diseases including cancer. This means more effective treatments and better quality of life for patients.
  • Arthritis, the disease: Arthritis is caused by an overactive immune system attacking the body's own tissues, most commonly the joints. This attack leads to inflammation, pain and joint damage. Nature's purpose of inflammation is to find and disarm the intruders, clean up damage and speed healing. In inflammation special components called play key roles.
  • Arthritis on the rise: Arthritis is a serious and debilitating disease that affects , tendons, bones and ligaments. According to the 2000 Canadian Community Health Survey arthritis affects almost four million Canadians and this number is estimated to reach six million in 2026. Arthritis is one of the major causes of pain and physical disability in Canada with an economic burden of around $4.4 billion. This is over 10 per cent of the total economic burden of all illnesses. Currently there is no cure for arthritis.
  • No magic arthritis pill, yet: Non-steroid anti-inflammatory drugs are commonly used to manage the symptoms of arthritis. However, these drugs are not specific to and can also cause serious side effects such as gastrointestinal bleeding. These and other complications further increase the costs to the Canadian health care system.

Explore further: Possible new approach to fighting chronic inflammatory diseases

Related Stories

Possible new approach to fighting chronic inflammatory diseases

July 30, 2012
(Medical Xpress) -- Researchers from The University of Queensland's Institute for Molecular Bioscience have discovered a potential new approach to treating chronic inflammatory diseases such as arthritis.

Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis

May 8, 2012
Untangling the root cause of rheumatoid arthritis has been a difficult task for immunologists, as decades of research has pointed to multiple culprits in our immune system, with contradictory lines of evidence. Now, researchers ...

Researcher examines the relationship between gum disease and arthritis

October 16, 2012
Adelaide scientists have found that mice with gum disease develop worse arthritis.

Scientists find new potential target for rheumatoid arthritis

March 5, 2012
Newcastle University scientists, in work funded by Arthritis Research UK, have discovered a new way of potentially treating rheumatoid arthritis. This works by preventing damaging white blood cells cells from entering the ...

New point of focus found for the treatment of rheumatoid arthritis and other autoimmune diseases

October 9, 2012
Scientists affiliated with VIB and UGent have discovered a mechanism used by the protein A20 to combat inflammation. This could be a very important point of focus in the search for a treatment for autoimmune diseases such ...

Recommended for you

Chronic inflammation causes loss of muscle mass during aging

January 12, 2018
People start losing muscle mass at the age of 40—about some 10 percent of the total muscle mass for each 10-year period, which may lead to fall-related injuries, slowing metabolism and reduced quality of life. Today, very ...

Breathing exercises help asthma patients with quality of life

December 13, 2017
A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught breathing ...

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.